Table 3.
Preoperative Karakiewicz | Postoperative Karakiewicz | Kattan | Cindolo | |
---|---|---|---|---|
No. studies | 4 | 7 | 4 | 2 |
Heterogeneity test | ||||
x2 | 0.40 | 0.40 | 0.02 | 0.20 |
df | 3 | 6 | 3 | 1 |
p value | 0.94 | 1.00 | 1.00 | 0.59 |
Combined Odds Ratio | ||||
OR | 8.47 | 8.82 | 6.52 | 2.61 |
95%CI | 2.79–25.70 | 2.08–37.40 | 1.80–23.57 | 1.58–4.30 |
Converted AUC (SE) | 0.810 (0.01) | 0.814 (0.01) | 0.780 (0.01) | 0.655 (0.01) |
Gain in predictive accuracy % (p value) | 0.004 (0.730)b | 0.125 (<0.01)f | - | |
0.030 (0.020)a | 0.034 (<0.01)d | |||
0.155 (<0.01)c | 0.159 (<0.01)e |
OR: odds ratio; AUC: area under the curve; CSS: cancer-specific survival; df: degree of freedom; CI: confidential interval; SE: standard error.
Preoperative Karakiewicz vs. Kattan;
Preoperative Karakiewicz vs. Postoperative Karakiewicz;
Preoperative Karakiewicz vs. Cindolo;
Postoperative Karakiewicz vs. Kattan;
Postoperative Karakiewicz vs. Cindolo;
Kattan vs. Cindolo.